We Must Use the Knowledge That We Have to Treat Patients With Acute Coronary Syndromes

This publication has 22 references indexed in Scilit:

• Impact of Combination Evidence-Based Medical Therapy on Mortality in Patients With Acute Coronary Syndromes
  Circulation, 2004
• Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study)
  The Lancet, 2003
• The underutilization of cardiacmedications of proven benefit, 1990 to 2002
  Journal of the American College of Cardiology, 2002
• Two decades of progress in preventing vascular disease
  The Lancet, 2002
• Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment Elevation
  New England Journal of Medicine, 2001
• Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients
  New England Journal of Medicine, 2000
• Long-term low-molecular-mass heparin in unstable coronary-artery disease: FRISC II prospective randomised multicentre study
  The Lancet, 1999
• Potential impact of evidence-based medicine in acute coronary syndromes: insights from GUSTO-IIb
  Journal of the American College of Cardiology, 1998
• Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels
  New England Journal of Medicine, 1998
• The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels
  New England Journal of Medicine, 1996